PhaseBio Pharmaceuticals (ELP Platform) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

PhaseBio Pharmaceuticals (ELP Platform) General Information

Description

Portfolio of an elastin-like polypeptide (ELP) technology based in Malvern, Pennsylvania.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Malvern, PA
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
ImmunoForge
Corporate Office
  • Malvern, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhaseBio Pharmaceuticals (ELP Platform) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PhaseBio Pharmaceuticals (ELP Platform)‘s full profile, request access.

Request a free trial

PhaseBio Pharmaceuticals (ELP Platform) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PhaseBio Pharmaceuticals (ELP Platform)‘s full profile, request access.

Request a free trial

PhaseBio Pharmaceuticals (ELP Platform) FAQs

  • Where is PhaseBio Pharmaceuticals (ELP Platform) headquartered?

    PhaseBio Pharmaceuticals (ELP Platform) is headquartered in Malvern, PA.

  • What industry is PhaseBio Pharmaceuticals (ELP Platform) in?

    PhaseBio Pharmaceuticals (ELP Platform)’s primary industry is Buildings and Property.

  • Is PhaseBio Pharmaceuticals (ELP Platform) a private or public company?

    PhaseBio Pharmaceuticals (ELP Platform) is a Private company.

  • What is PhaseBio Pharmaceuticals (ELP Platform)’s current revenue?

    The current revenue for PhaseBio Pharmaceuticals (ELP Platform) is .

  • Who are PhaseBio Pharmaceuticals (ELP Platform)’s investors?

    PhaseBio Pharmaceuticals has invested in PhaseBio Pharmaceuticals (ELP Platform).

  • When was PhaseBio Pharmaceuticals (ELP Platform) acquired?

    PhaseBio Pharmaceuticals (ELP Platform) was acquired on 01-Feb-2023.

  • Who acquired PhaseBio Pharmaceuticals (ELP Platform)?

    PhaseBio Pharmaceuticals (ELP Platform) was acquired by ImmunoForge.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process